0001144204-16-101006.txt : 20160512 0001144204-16-101006.hdr.sgml : 20160512 20160512080107 ACCESSION NUMBER: 0001144204-16-101006 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160512 DATE AS OF CHANGE: 20160512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SHARED HOSPITAL SERVICES CENTRAL INDEX KEY: 0000744825 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 942918118 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08789 FILM NUMBER: 161641682 BUSINESS ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 BUSINESS PHONE: 415-788-5300 MAIL ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 10-Q 1 v438642_10q.htm 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 10-Q

 

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2016 or

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________.

 

Commission file number 1-08789

 

 

 

American Shared Hospital Services

(Exact name of registrant as specified in its charter)

 

California 94-2918118
(State or other jurisdiction of (IRS Employer
Incorporation or organization) Identification No.)

 

Four Embarcadero Center, Suite 3700, San Francisco, California 94111
(Address of Principal Executive Offices) (Zip Code)

 

Registrant’s telephone number, including area code: (415) 788-5300

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer ¨ Accelerated Filer ¨ Non-Accelerated Filer ¨ Smaller reporting company x

 

As of May 1, 2016, there are outstanding 5,364,000 shares of the Registrant’s common stock.

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED BALANCE SHEETS 

 

   (unaudited)     
   March 31, 2016   December 31, 2015 
ASSETS          
           
Current assets:          
Cash and cash equivalents  $2,140,000   $2,209,000 
Restricted cash   50,000    50,000 
Accounts receivable, net of allowance for doubtful accounts of $100,000 at March 31, 2016 and $100,000 at December 31, 2015   3,557,000    3,038,000 
           
Other receivables   88,000    107,000 
Prepaid expenses and other current assets   531,000    570,000 
           
Total current assets   6,366,000    5,974,000 
           
Property and equipment:          
Medical equipment and facilities   83,367,000    83,267,000 
Office equipment   722,000    721,000 
Deposits and construction in progress   17,899,000    10,796,000 
    101,988,000    94,784,000 
Accumulated depreciation and amortization   (49,228,000)   (47,661,000)
Net property and equipment   52,760,000    47,123,000 
           
Investment in equity securities   579,000    579,000 
Other assets   382,000    366,000 
           
Total assets  $60,087,000   $54,042,000 

  

  (unaudited)     
  March 31, 2016   December 31, 2015 
LIABILITIES AND SHAREHOLDERS’ EQUITY        
        
Current liabilities:          
Accounts payable  $531,000   $375,000 
Employee compensation and benefits   198,000    156,000 
Other accrued liabilities   1,052,000    1,162,000 
           
Current portion of long-term debt   2,637,000    2,641,000 
Current portion of obligations under capital leases   4,767,000    4,331,000 
           
Total current liabilities   9,185,000    8,665,000 
           
Long-term debt, less current portion   5,567,000    6,884,000 
Long-term capital leases, less current portion   15,697,000    9,190,000 
Deferred revenue, less current portion   689,000    719,000 
           
Deferred income taxes   3,468,000    3,404,000 
           
Shareholders’ equity:          
Common stock (10,000,000 authorized; 5,364,000 shares issued and outstanding at March 31, 2016
and December 31, 2015)		   10,376,000    10,376,000 
Additional paid-in capital   5,793,000    5,734,000 
Retained earnings   4,071,000    4,020,000 
Total equity-American Shared Hospital Services   20,240,000    20,130,000 
Non-controlling interest in subsidiary   5,241,000    5,050,000 
Total shareholders’ equity   25,481,000    25,180,000 
           
Total liabilities and shareholders’ equity  $60,087,000   $54,042,000 

 

See accompanying notes

 

 2 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months ended March 31, 
   2016   2015 
         
Medical services revenue  $4,238,000   $4,117,000 
           
Costs of revenue:          
           
Maintenance and supplies   244,000    333,000 
           
Depreciation and amortization   1,562,000    1,505,000 
           
Other direct operating costs   699,000    682,000 
           
    2,505,000    2,520,000 
           
Gross Margin   1,733,000    1,597,000 
           
Selling and administrative expense   949,000    821,000 
           
Interest expense   285,000    320,000 
           
Operating income   499,000    456,000 
           
(Loss) on early extinguishment of debt   (108,000)   - 
           
Interest and other income   5,000    6,000 
           
Income before income taxes   396,000    462,000 
           
Income tax expense   64,000    130,000 
           
Net income   332,000    332,000 
Less: Net income attributable to non-controlling interest   (281,000)   (204,000)
           
Net income attributable to American Shared Hospital Services  $51,000   $128,000 
           
Net income per share:          
           
Earnings per common share - basic  $0.01   $0.02 
           
Earnings per common share - diluted  $0.01   $0.02 

 

See accompanying notes

 

 3 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY

 

   YEAR ENDED DECEMBER 31, 2015 AND THREE MONTH PERIOD MARCH 31, 2016 
           Additional           Non-controlling     
   Common   Common   Paid-in   Retained   Sub-Total   Interests in     
   Shares   Stock   Capital   Earnings   ASHS   Subsidiaries   Total 
                             
Balances at January 1, 2015   5,361,000   $10,376,000   $5,508,000   $5,542,000   $21,426,000   $4,728,000   $26,154,000 
                                    
Stock-based compensation expense   3,000    -    226,000    -    226,000    -    226,000 
                        -           
Non-controlling interest investment in subsidiaries   -    -    -    -    -    46,000    46,000 
                                    
Cash distributions to non-controlling interests   -    -    -    -    -    (670,000)   (670,000)
                                    
Net (loss) income   -    -    -    (1,522,000)   (1,522,000)   946,000    (576,000)
                                    
Balances at December 31, 2015   5,364,000    10,376,000    5,734,000    4,020,000    20,130,000    5,050,000    25,180,000 
                                    
Stock-based compensation expense   -    -    59,000    -    59,000    -    59,000 
                        -           
Non-controlling interest investment in subsidiaries   -    -    -    -    -    7,000    7,000 
                                    
Cash distributions to non-controlling interests   -    -    -    -    -    (97,000)   (97,000)
                                    
Net income   -    -    -    51,000    51,000    281,000    332,000 
                                    
Balances at March 31, 2016   5,364,000   $10,376,000   $5,793,000   $4,071,000   $20,240,000   $5,241,000   $25,481,000 

 

See accompanying notes

 

 4 

 

 

AMERICAN SHARED HOSPITAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   Three Months ended March 31, 
   2016   2015 
Operating activities:          
Net income  $332,000   $332,000 
           
Adjustments to reconcile net income to net cash from operating activities:          
           
Depreciation and amortization   1,574,000    1,517,000 
           
(Gain) on sale of assets   (1,000)   - 
           
Loss on early extinguishment of debt   108,000    - 
           
Deferred income tax   64,000    - 
           
Stock-based compensation expense   59,000    36,000 
           
Other non-cash items   4,000    12,000 
           
Changes in operating assets and liabilities:          
           
Receivables   (500,000)   (735,000)
           
Prepaid expenses and other assets   22,000    9,000 
           
Customer deposits/deferred revenue   (78,000)   17,000 
           
Accounts payable and accrued liabilities   136,000    141,000 
           
Net cash from operating activities   1,720,000    1,329,000 
           
Investing activities:          
Payment for purchase of property and equipment   (333,000)   (188,000)
           
Net cash used in investing activities   (333,000)   (188,000)
           
Financing activities:          
Principal payments on long-term debt   (1,439,000)   (401,000)
           
Principal payments on capital leases   (1,064,000)   (1,004,000)
           
Proceeds from certificate of deposit   -    9,000,000 
           
Payments on line of credit   -    (8,780,000)
           
Capital contributions from non-controlling interests   7,000    - 
           
Distributions to non-controlling interests   (97,000)   (88,000)
           

Proceeds from capital lease financing for reimbursement of payments for acquisition of equipment

   1,137,000    - 
           
Net cash used in financing activities   (1,456,000)   (1,273,000)
           
Net change in cash and cash equivalents   (69,000)   (132,000)
           
Cash and cash equivalents at beginning of period   2,209,000    1,059,000 
           
Cash and cash equivalents at end of period  $2,140,000   $927,000 
           
Supplemental cash flow disclosure:          
Cash paid during the period for:          
           
Interest  $515,000   $438,000 
           
Income taxes (refunds)  $96,000   $(5,000)
           
Schedule of non-cash investing and financing activities          
Acquisition of equipment with capital lease financing  $6,870,000   $1,160,000 

 

See accompanying notes

 

 5 

 

  

AMERICAN SHARED HOSPITAL SERVICES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1. Basis of Presentation

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of March 31, 2016 and the results of its operations for the three month periods ended March 31, 2016 and 2015, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2015 have been derived from audited consolidated financial statements.

 

These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2015 included in the Company’s 10-K filed with the Securities and Exchange Commission.

 

These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the “Company”) and its subsidiaries as follows: The Company wholly-owns the subsidiaries OR21, Inc. (“OR21 LLC”), MedLeader.com, Inc. (“MedLeader”), PBRT Orlando, LLC (“Orlando”) and American Shared Radiosurgery Services (“ASRS”). The Company is also the majority owner of Long Beach Equipment, LLC (“LBE”). ASRS is the majority-owner of GK Financing, LLC (“GKF”) which wholly-owns the subsidiaries GK Financing U.K., Limited (“GKUK”), and Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”). GKF is also the majority-owner of the subsidiaries Albuquerque GK Equipment, LLC (“AGKE”) and Jacksonville GK Equipment, LLC (“JGKE”).

 

The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of March 31, 2016 in the states of Arkansas, California, Oregon, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.

 

The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.

 

The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California and Orlando, Florida; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. Orlando treated its first patient in April 2016. GKPeru is expected to begin operation in mid-2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.

 

 6 

 

 

The Company continues to develop its design and business model for “The Operating Room for the 21st Century” SM (“OR21” SM), through its 50% owned OR21, LLC. The remaining 50% is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.

 

MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses and other healthcare workers. This subsidiary is not operational at this time.

 

Based on the guidance provided in accordance with Accounting Standards Codification (“ASC”) 280 Segment Reporting (“ASC 280”), the Company has analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there is one reportable segment, Medical Services Revenue. The Company provides Gamma Knife and IGRT equipment to seventeen hospitals in the United States as of March 31, 2016. These seventeen locations operate under different subsidiaries of the Company, but offer the same service, radiosurgery and radiation therapy. The operating results of the subsidiaries are reviewed by the Company’s Chief Executive Officer and Chief Financial Officer, who are also deemed the Company’s Chief Operating Decision Makers (“CODMs”) and this is done in conjunction with all of the subsidiaries and locations.

 

On January 14, 2016, the Company entered into a definitive lease agreement for financing of its MEVION S250 at UF Health Cancer Center at Orlando Health. The proceeds of $7,900,000 received to date, from this financing of approximately $8,400,000, were used to pay-down the $1,000,000 in Promissory Notes (the “Notes”) with four members of the Company’s Board of Directors, reimburse the Company for freight costs associated with the MEVION S250, and to fund one of the remaining milestone payments for the MEVION S250 of approximately $6,700,000. Total proceeds from capital lease financing for reimbursement of payments for acquisition of equipment, were approximately $1,137,000.

 

Based on the guidance provided in accordance with ASC 405 Extinguishment of Liabilities (“ASC 405”) and ASC 470 Debt Modifications and Extinguishments (“ASC 470”), the pay-down of the Notes is considered an extinguishment of debt and, as such, the difference between the net carrying amount of the Notes and the costs of extinguishment were recognized as a loss on the Company’s condensed consolidated Statements of Operations. For the three month period ended March 31, 2016, the loss on early extinguishment of debt was $108,000. The Notes were issued with common stock warrants with an estimated fair value of $145,000. The unamortized balance of the discount on the Notes, of $80,000, and deferred fees incurred from the issuance of the Note of approximately $28,000, were recorded as loss on early extinguishment.

 

In May 2014, the Financial Accounting Standards Board “(FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in United States Generally Accepted Accounting Principles (“GAAP”) when it becomes effective. The new standard is effective for the Company for annual reporting periods beginning after December 15, 2017. Early application is permitted for reporting periods beginning after December 15, 2016. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.

 

In August 2014, FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”), which provides guidance on determining when and how to disclose going-concern uncertainties in financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is currently evaluating the impact of this update on future disclosures concerning its liquidity position.

 

 7 

 

 

In January 2015, the FASB issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items (“ASU 2015-01”), which eliminates from GAAP the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with International Accounting Standards (“IAS”) 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The new standard was effective for the Company on January 1, 2016. The standard permits the use of either the retrospective or prospective application. The Company adopted ASU 2015-01 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.

 

In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard was effective for the Company on January 1, 2016. The Company adopted ASU 2015-02 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.

 

In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard was effective for the Company on January 1, 2016.

 

The Company adopted ASU 2015-03 on January 1, 2016, on a retrospective basis. Debt issuance costs that were previously recorded as other assets on the Company’s condensed consolidated Balance Sheets were reclassified as an offset to the respective debt instrument for which they were derived. As of March 31, 2016 and December 31, 2015, $67,000 and $72,000 were reclassified from current and noncurrent other assets to current and noncurrent debt, respectively.

 

In January 2016, the FASB issued ASU No. 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”) which requires equity investments, except those accounted for under the equity method of accounting or those that result in consolidation of the investee, to be measured at fair value with changes in fair value recognized in net income. The new guidance is effective for the Company on January 1, 2018. Early adoption is permitted. The standard permits the use of cumulative-effect transition method. The Company is evaluating the effect that ASU 2016-01 will have on its consolidated financial statements and related disclosures.

 

 8 

 

 

In February 2016, the FASB issued ASU No. 2016-02 Leases (“ASU 2016-02”), which requires lessees to recognize, for all leases, at the commencement date, a lease liability and a right-of-use asset. Under the new guidance, lessor accounting is largely unchanged. The new guidance is effective for the Company on January 1, 2019. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-02 will have on its consolidated financial statements and related disclosures.

 

In March 2016, the FASB issued ASU No. 2016-09 Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”) which changes five aspects of accounting for share-based payment award transactions including 1) accounting for income taxes; 2) classification of excess tax benefits on the statement of cash flows; 3) forfeitures; 4) minimum statutory tax withholding requirements; 5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. The new guidance is effective for the Company for interim and annual periods beginning after December 15, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-09 will have on its consolidated financial statements and related disclosures.

 

Note 2.Per Share Amounts

 

Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding. The computation for the three month periods ended March 31, 2016 and 2015 excluded approximately 617,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during those periods.

 

The following table sets forth the computation of basic and diluted earnings per share for the three month periods ended March 31, 2016 and 2015:

 

   Three Months ended March 31, 
   2016   2015 
Net income attributable to American Shared Hospital Services  $51,000   $128,000 
           
Weighted average common shares for basic earnings per share   5,541,000    5,477,000 
Diluted effect of stock options and restricted stock   -    49,000 
Weighted average common shares for diluted earnings per share   5,541,000    5,526,000 
           
Basic earnings per share  $0.01   $0.02 
Diluted earnings per share  $0.01   $0.02 

 

 

 9 

 

 

Note 3.Stock-based Compensation

 

On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company’s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.

 

Stock-based compensation expense associated with the Company’s stock-based options to employees is calculated using the Black-Scholes valuation model. The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect, for the Company’s options and restricted stock awards, in the amount of $59,000 and $36,000 is reflected in net income for the three month periods ended March 31, 2016 and 2015. At March 31, 2016, there was approximately $440,000 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately four years.

 

The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the three month period ended March 31, 2016:

  

   Restricted
Stock
Awards/Units		   Grant Date
Weighted-
Average Fair
Value		   Intrinsic
Value		 
Outstanding at January 1, 2016   3,000   $2.58   $- 
Granted   32,000   $1.89   $- 
Vested   (8,000)  $1.89   $- 
Forfeited   -   $-   $- 
Outstanding at March 31, 2016   27,000   $1.97   $7,000 

 

 10 

 

 

The following table summarizes stock option activity for the three month period ended March 31, 2016:

 

   Stock
Options		   Grant Date
Weighted-
Average
Exercise
Price		   Weighted-
Average
Remaining
Contractual
Life (in
Years)		 
Outstanding at January 1, 2016   614,000   $2.86    5.10 
Granted   3,000   $1.90    6.94 
Exercised   -   $-    - 
Forfeited   -   $-    - 
Outstanding at March 31, 2016   617,000   $2.85    4.86 
Exercisable at March 31, 2016   82,000   $2.74    2.69 

 

Note 4.Investment in Equity Securities

 

As of March 31, 2016 and December 31, 2015 the Company had a $579,000 investment in the common stock of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, Inc., representing an approximate 0.46% interest in Mevion. The Company accounts for this investment under the cost method.

 

The Company carries its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable. During the period ended December 31, 2015, the Company determined that its investment was other than temporarily impaired. In determining the fair value of the Company’s common stock in Mevion, the Company engaged a third party expert to review and corroborate its assessment of the fair value of the investment. The third party utilized the market approach and an option waterfall model calibrated to Mevion’s last round of funding. Each equity class was examined and priced according to its liquidation preferences. The fair value of the Company’s investment in Mevion, as of December 31, 2015, was approximately $579,000 with an impairment loss for the year then ended of $2,140,000.

 

The Company reviewed this investment at March 31, 2016 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room proton beam radiation therapy (“PBRT”) system. Based on its analysis, the Company determined no additional impairment needs to be recognized as of March 31, 2016.

 

The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (“Barnes-Jewish Hospital”), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (“Ackerman Cancer Center”), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (“Robert Wood Johnson”), started in May 2015. The Company’s first MEVION S250 treated its first patient on April 6, 2016.

 

 11 

 

 

Note 5.Fair Value of Financial Instruments

 

The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. The estimated fair value of the Company’s assets and liabilities as of March 31, 2016 and December 31, 2015 were as follows (in thousands):

 

   Level 1   Level 2   Level 3   Total   Carrying
Value		 
March 31, 2016                         
                          
Assets:                         
Cash, cash equivalents, restricted cash  $2,190   $-   $-   $2,190   $2,190 
Investment in equity securities   -    -    579    579    579 
Total  $2,190   $-   $579   $2,769   $2,769 
                          
Liabilities                         
Debt obligations  $-   $-   $8,321   $8,321   $8,204 
Total  $-   $-   $8,321   $8,321   $8,204 
                          
December 31, 2015                         
                          
Assets:                         
Cash, cash equivalents, restricted cash  $2,259   $-   $-   $2,259   $2,259 
Investment in equity securities   -    -    579    579    579 
Total  $2,259   $-   $579   $2,838   $2,838 
                          
Liabilities                         
Debt obligations  $-   $-   $9,744   $9,744   $9,525 
Total  $-   $-   $9,744   $9,744   $9,525 

 

Note 6.Repurchase of Common Stock

 

In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2016 or 2015. There are approximately 72,000 shares remaining under this repurchase authorization.

 

 12 

 

 

Note 7.Income Taxes

 

We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three month periods ended March 31, 2016 and 2015 by applying the actual effective tax rates to income reported within the condensed consolidated financial statements through those periods.

 

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This quarterly report to the Securities and Exchange Commission may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st CenturySM program, and the risks of investing in Mevion. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 and the definitive Proxy Statement for the Annual Meeting of Shareholders held to be held on June 21, 2016.

 

The Company had seventeen Gamma Knife units in operation at March 31, 2016 and eighteen at March 31, 2015. One Gamma Knife customer contract expired after the first quarter of 2015. Two of the Company’s customer contracts are through subsidiaries where GKF or its subsidiary is the majority owner and managing partner. Ten of the Company’s seventeen current Gamma Knife customers are under fee-per-use contracts, and seven customers are under retail arrangements. The Company’s contract to provide radiation therapy and related equipment services to an existing Gamma Knife customer is also considered a retail arrangement. Retail arrangements are further classified as either turn-key or revenue sharing. Revenue from fee per use contracts is determined by each hospital’s contracted rate. For revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. Under turn-key arrangements, the Company receives payment from the hospital in the amount of its reimbursement from third party payors, and is responsible for paying all the operating costs of the equipment. Operating costs are determined primarily based on historical treatment protocols and cost schedules with the hospital. The Company records an estimate of operating costs which are reviewed on a regular basis and adjusted as necessary to more accurately reflect the actual operating costs. For the turn-key sites, the Company also shares a percentage of net operating profit. The Company records an estimate of net operating profit based on estimated revenues, less estimated operating costs.

 

 13 

 

 

Prior to April 1, 2013, Medicare’s reimbursement rate for Gamma Knife treatment had been relatively stable. Congress’s enactment of the American Taxpayer Relief Act of 2012, however, reduced Medicare’s Gamma Knife reimbursement rate from approximately $9,900 to $5,300, effective April 1, 2013. This change caused a substantial reduction in the Company’s revenues during 2013 and 2014. Effective January 1, 2015, the Centers for Medicare and Medicaid (CMS) established a Comprehensive Ambulatory Payment Classification for single session radiosurgery treatments, which increased the reimbursement rate (for a Medicare Gamma Knife treatment) by approximately $4,100 to $9,700. CMS has established a 2016 total reimbursement rate of approximately $8,800 for a Medicare Gamma Knife treatment.

 

Medical services revenue increased by $121,000 to $4,238,000 for the three month period ended March 31, 2016 from $4,117,000 for the three month period ended March 31, 2015. Excluding the customer contract that expired after the first quarter 2015, Gamma Knife revenue increased $374,000 compared to the prior year. The increase in Gamma Knife revenue was due to a favorable payor mix at the Company’s retail sites and increased volume at existing sites. Revenue from the Company’s radiation therapy contract, however, decreased slightly for the three month period by $6,000, to $113,000 from $119,000 for the same period in the prior year. The decrease was due to a decline in volume.

 

The number of Gamma Knife procedures increased by 2 to 481 in the first quarter 2016 from 479 in the same quarter in the prior year. Excluding the customer contract that expired after the first quarter 2015, Gamma Knife procedures increased 28 or 6.2% compared to prior year. The increase was due to increased volume at existing sites plus two sites which were inactive during part of the first quarter of 2015.

 

Total costs of revenue decreased by $15,000 to $2,505,000 for the three month period ended March 31, 2016 from $2,520,000 for the three month period ended March 31, 2015. Maintenance and supplies decreased by $89,000 for the three month period ended March 31, 2016 compared to the same period in the prior year, due to lower maintenance costs at existing sites. Depreciation and amortization increased by $57,000 for the three month period ended March 31, 2016 compared to the same period in the prior year. This was due to two Cobalt-60 reloads which were done in the first and second quarters of 2015. When a Cobalt-60 reload is performed the book value of the unit increases which increases depreciation expense. Other direct operating costs decreased by $17,000 for the three month period ended March 31, 2016 compared to the same period in the prior year. The decrease was due to lower marketing and insurance costs, offset by increased operating costs at the Company’s retail sites.

 

Selling and administrative costs increased by $128,000 to $949,000 for the three month period ended March 31, 2016 from $821,000 for the three month period ended March 31, 2015. This increase was primarily due to increased accounting and consulting fees, and payroll expense. Payroll expense increased because the Company hired its temporary Senior Accountant to a full time position effective July 1, 2015.

 

 14 

 

 

Interest expense decreased by $35,000 to $285,000 for the three month period ended March 31, 2016 from $320,000 for the three month period ended March 31, 2015. The Company had a lower average principal base in the first quarter of 2016, compared to prior year, effectively reducing interest expense.

 

The Company incurred a loss on early extinguishment of debt of $108,000 for the three month period ended March 31, 2016, compared to $0 in the same period prior year. In February 2016, the Company used a portion of the proceeds from the lease financing for its first MEVION S250 to pay down the $1,000,000 Notes pursuant to a note agreement between four members of the Company’s Board of Directors. The Note agreements permit for early payment without penalty to the Company. The Notes were issued with common stock warrants with an estimated fair value of $145,000. The unamortized balance of the discount on the Notes, of $80,000, and deferred fees incurred from the issuance of the Notes of approximately $28,000, were recorded as a loss on early extinguishment of debt on the Company’s condensed consolidated Statement of Operations as of March 31, 2016.

 

Interest and other income decreased by $1,000 to $5,000 for the three month period ended March 31, 2016 from $6,000 for the three month period ended March 31, 2015. Interest and other income is generated from deferred revenue and interest earned on investments.

 

The Company had income tax expense of $64,000 for the three month period ended March 31, 2016 compared to income tax expense of $130,000 for the three month period ended March 31, 2015. The decrease in income tax expense is primarily due to lower taxable income attributable to the Company, driven by the loss on early extinguishment of debt.

 

Net income attributable to non-controlling interest increased by $77,000 to $281,000 for the three month period ended March 31, 2016 from $204,000 for the three month period ended March 31, 2015. Net income attributable to non-controlling interests represents net income earned by the 19% non-controlling interest in GKF, and net income of the non-controlling interests in various subsidiaries controlled by GKF. The decrease or increase in net income attributable to non-controlling interests reflects the relative profitability of GKF.

 

The Company had net income of $51,000, or $0.01 per basic and diluted share, for the three month period ended March 31, 2016 compared to net income of $128,000, or $0.02 per basic and diluted share, in the same period in the prior year. Excluding the loss on early extinguishment of debt, net of tax, net income decreased $13,000 to $115,000. The decrease in net income was primarily due to the loss on early extinguishment of debt and higher selling and administrative costs, offset by an increase in medical services revenue.

 

Liquidity and Capital Resources

 

The Company had cash and cash equivalents of $2,140,000 at March 31, 2016 compared to $2,209,000 at December 31, 2015. The Company’s cash position decreased by $69,000 due to payments for the purchase of property and equipment of $333,000, principal payments on long term debt and capital leases of $2,503,000, and distributions to non-controlling interests of $97,000. These decreases were offset by net cash from operating activities of $1,720,000, capital contributions from non-controlling interests of $7,000, and proceeds from capital lease financing for reimbursement of payments for acquisition of equipment of $1,137,000.

 

 15 

 

 

The Company had cash and cash equivalents of $927,000 at March 31, 2015 compared to $1,059,000 at December 31, 2014. The Company’s cash position decreased by $132,000 due to payments for the purchase of property and equipment of $188,000, principal payments on long term debt and capital leases of $1,405,000, and distributions to non-controlling interests of $88,000. These decreases were offset by net cash from operating activities of $1,329,000 and net proceeds from the certificate of deposit and pay-down on the line of credit of $220,000.

 

The Company has scheduled interest and principal payments under its debt obligations of approximately $3,124,000 and scheduled capital lease payments of approximately $6,076,000 during the next 12 months. The Company believes that its cash flow from cash on hand, operations, and other cash resources are adequate to meet its scheduled debt and capital lease obligations during the next 12 months. See additional discussion below related to commitments.

 

The Company as of March 31, 2016 had shareholders’ equity of $25,481,000, negative working capital of $2,819,000 and total assets of $60,087,000.

 

Commitments

 

As of March 31, 2016, the Company had commitments to purchase two MEVION S250 PBRT systems for $25,800,000 and the Company had $2,000,000 in non-refundable deposits toward the purchase of these two PBRT systems from Mevion. The non-refundable deposits are recorded in the Condensed Consolidated Balance Sheets as deposits and construction in progress. The Company’s first MEVION S250 synchrocyclotron treated its first patient in April 2016. In January 2016, the Company secured lease financing of approximately $8,400,000 and payment of $6,700,000 was remitted to Mevion. The financing company also reimbursed the Company approximately $1,100,000 in previously remitted progress payments to Mevion and freight costs. An additional payment of approximately $600,000 is due to Mevion in two installments during 2016 which will be paid using the remaining proceeds from the January 2016 lease financing.

 

The Company and Mevion have not agreed on construction and delivery timetables for the second and third PBRT units for which the Company has purchase commitments. The Company is actively seeking sites for these units but to date has not entered into agreements with any party for either placement of a PBRT unit or the related financing. In the past, the Company and Mevion have established construction and delivery timetables, and therefore progress payment dates, only after the Company has notified Mevion that there is a proposed site for the unit. Accordingly, the timing of the required payments for the remaining $25,800,000 of the Company’s purchase commitments remains uncertain. The Company’s position is that these payments should not commence until a site is available for a PBRT unit and the related financing is in place.

 

 16 

 

 

As of March 31, 2016, the Company had commitments to purchase one Gamma Knife Perfexion system and one Cobalt-60 reload, and is scheduled to install one Gamma Knife Model 4C system, which the Company previously financed and owns. The loan to finance the Company’s unit in Peru is guaranteed by GKF and collateralized by the Company’s stock in the subsidiary, IGKP. Total Gamma Knife commitments as of March 31, 2016 were $3,650,000. The Model 4C unit is scheduled to be installed in mid-2016 at the Company’s new customer site in Peru. There are cash requirements for the Peru commitment in the next 12 months of approximately $600,000. The Company believes that cash flow from cash on hand and operations will be sufficient to cover this payment. The Perfexion unit is for a site yet to be determined and it is the Company’s intent to finance this unit. The Cobalt-60 reload is for an existing site and it is the Company’s intent to finance this reload. There are no significant cash requirements, pending financing, for the Perfexion system or the Cobalt-60 reload in the next 12 months. There can be no assurance that financing will be available for the Company’s current or future projects, or at terms that are acceptable to the Company.

 

The Company estimates the following commitments for each of the equipment systems with expected timing of payments as follows as of March 31, 2016:

 

   2016   Thereafter   Total 
             
Proton Beam Units  $600,000   $25,800,000   $26,400,000 
                
Gamma Knife Units   3,650,000    -    3,650,000 
                
Total  $4,250,000   $25,800,000   $30,050,000 

 

Item 3.Quantitative and Qualitative Disclosures about Market Risk

 

The Company does not hold or issue derivative instruments for trading purposes and is not a party to any instruments with leverage or prepayment features. The Company does not have affiliation with partnerships, trust or other entities whose purpose is to facilitate off-balance sheet financial transactions or similar arrangements, and therefore has no exposure to the financing, liquidity, market or credit risks associated with such entities. At March 31, 2016 the Company had no significant long-term, market-sensitive investments.

 

Item 4.Controls and Procedures

 

Under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934. These controls and procedures are designed to ensure that material information relating to the company and its subsidiaries is communicated to the chief executive officer and the chief financial officer. Based on that evaluation, our chief executive officer and our chief financial officer concluded that, as of March 31, 2016, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to the chief executive officer and the chief financial officer, and recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

 17 

 

 

There were no changes in our internal control over financial reporting during the three months ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1.Legal Proceedings.

None.

 

Item 1A.Risk Factors

There are no changes from those listed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds.

None.

 

Item 3.Defaults Upon Senior Securities.

None.

 

Item 4.Mine Safety Disclosures

Not applicable.

 

Item 5. Other Information.

None.

  

 18 

 

 

Item 6.Exhibit Index

 

            Incorporated by reference herein

Exhibit

Number

       Description   Form   Exhibit   Date
31.1   *   Certification of Chief Executive Officer pursuant to Rule 13a-14a/15d-14a, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002            
31.2   *   Certification of Chief Financial Officer pursuant to Rule 13a-14a/15d-14a, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002            
32.1   #   Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002            
101.INS   *   XBRL Instance Document            
101.SCH   *   XBRL Taxonomy Extension Schema Document            
101.CAL   *   XBRL Taxonomy Calculation Linkbase Document            
101.DEF   *   XBRL Taxonomy Definition Linkbase Document            
101.LAB   *   XBRL Taxonomy Label Linkbase Document            
101.PRE   *   XBRL Taxonomy Extension Presentation Linkbase Document            
                     
    *    Filed herewith.            
    #   Furnished herewith.            

  

 19 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMERICAN SHARED HOSPITAL SERVICES

Registrant

 

Date: May 12, 2016 /s/ Ernest A. Bates, M.D.
    Ernest A. Bates, M.D.
    Chairman of the Board and Chief Executive Officer
     
     
Date: May 12, 2016 /s/ Craig K. Tagawa
    Craig K. Tagawa
    Senior Vice President
    Chief Operating and Financial Officer

 

 20 

 

 EX-31.1 2 v438642_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION

 

I, Ernest A. Bates, M.D., as chief executive officer of American Shared Hospital Services, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

  

May 12, 2016  
   
/s/ Ernest A. Bates, M.D.  
Ernest A. Bates, M.D.  
   
Chief Executive Officer  

 

 

 

 EX-31.2 3 v438642_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION

 

I, Craig K. Tagawa., as chief financial officer of American Shared Hospital Services, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

  

May 12, 2016  
   
/s/ Craig K. Tagawa  
Craig K. Tagawa  
   
Chief Financial Officer  

 

 

 EX-32.1 4 v438642_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of American Shared Hospital Services for the quarterly period ended March 31, 2016 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Ernest A. Bates, M.D., the Chief Executive Officer and Craig K. Tagawa, the Chief Financial Officer of American Shared Hospital Services, each certifies that, to the best of his knowledge:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of American Shared Hospital Services.

 

May 12, 2016  
   
  /s/ Ernest A. Bates, M.D.
  Ernest A. Bates, M.D.
  Chief Executive Officer
   
  /s/ Craig K. Tagawa
  Craig K. Tagawa
  Chief Financial Officer

 

 

 

 EX-101.INS 5 ams-20160331.xml XBRL INSTANCE DOCUMENT 0000744825 2015-01-01 2015-03-31 0000744825 2015-01-01 2015-12-31 0000744825 2016-01-01 2016-03-31 0000744825 2016-03-31 0000744825 2016-05-01 0000744825 2008-12-31 0000744825 2015-12-31 0000744825 2014-12-31 0000744825 2015-03-31 0000744825 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0000744825 us-gaap:ParentMember 2016-01-01 2016-03-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0000744825 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-03-31 0000744825 us-gaap:CommonStockMember 2016-01-01 2016-03-31 0000744825 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0000744825 us-gaap:ParentMember 2015-01-01 2015-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0000744825 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0000744825 us-gaap:CommonStockMember 2015-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000744825 us-gaap:RetainedEarningsMember 2015-12-31 0000744825 us-gaap:ParentMember 2015-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2015-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000744825 us-gaap:CommonStockMember 2014-12-31 0000744825 us-gaap:ParentMember 2014-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2014-12-31 0000744825 us-gaap:RetainedEarningsMember 2014-12-31 0000744825 us-gaap:CommonStockMember 2016-03-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0000744825 us-gaap:RetainedEarningsMember 2016-03-31 0000744825 us-gaap:ParentMember 2016-03-31 0000744825 us-gaap:NoncontrollingInterestMember 2016-03-31 0000744825 ams:Or21LlcMember 2016-03-31 0000744825 ams:ArchitecturalDesignCompanyMember 2016-03-31 0000744825 ams:MevionMedicalSystemsIncMember 2015-12-31 0000744825 ams:MevionMedicalSystemsIncMember 2015-01-01 2015-12-31 0000744825 ams:MevionMedicalSystemsIncMember 2016-03-31 0000744825 us-gaap:FairValueInputsLevel1Member 2016-03-31 0000744825 us-gaap:FairValueInputsLevel2Member 2016-03-31 0000744825 us-gaap:FairValueInputsLevel3Member 2016-03-31 0000744825 us-gaap:FairValueInputsLevel1Member 2015-12-31 0000744825 us-gaap:FairValueInputsLevel2Member 2015-12-31 0000744825 us-gaap:FairValueInputsLevel3Member 2015-12-31 0000744825 ams:IncentiveCompensationPlanMember 2010-06-02 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MinimumMember 2010-06-02 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MaximumMember 2010-06-02 0000744825 ams:MevionMedicalSystemsIncMember 2016-01-01 2016-01-14 0000744825 ams:MevionMedicalSystemsIncMember 2016-01-14 0000744825 ams:NotesPayableMember 2016-03-31 0000744825 ams:AccountingStandardsUpdate201503Member 2016-03-31 0000744825 ams:AccountingStandardsUpdate201503Member 2015-12-31 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2015-12-31 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2016-03-31 0000744825 ams:IncentiveCompensationPlanMember 2016-03-31 0000744825 ams:NotesPayableMember 2016-01-01 2016-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2016-03-31 2016 Q1 AMERICAN SHARED HOSPITAL SERVICES 0000744825 --12-31 Smaller Reporting Company AMS 5364000 2140000 2209000 50000 50000 3557000 3038000 88000 107000 531000 570000 6366000 5974000 52760000 47123000 60087000 579000 579000 382000 366000 54042000 531000 375000 198000 156000 1052000 1162000 2637000 2641000 4767000 4331000 9185000 8665000 5567000 6884000 15697000 9190000 689000 719000 3468000 3404000 10376000 10376000 5793000 5734000 4071000 5050000 60087000 54042000 25481000 25180000 5241000 20130000 20240000 4020000 821000 320000 4117000 333000 1505000 682000 1597000 456000 6000 462000 130000 332000 204000 128000 0.02 0.02 949000 285000 4238000 244000 1562000 699000 1733000 499000 5000 396000 64000 332000 281000 51000 0.01 0.01 0 59000 59000 0 59000 0 7000 0 0 0 0 7000 51000 281000 0 0 51000 0 0 97000 670000 0 0 0 670000 97000 0 0 0 10376000 5734000 4020000 20130000 5050000 5364000 0 5508000 26154000 10376000 21426000 4728000 5542000 5361000 226000 0 226000 0 3000 226000 0 46000 0 0 0 0 46000 0 0 -1522000 -1522000 946000 -576000 10376000 5793000 4071000 20240000 5241000 5364000 -9000 -22000 141000 136000 1329000 1720000 1517000 1574000 -5000 96000 1160000 6870000 0 64000 36000 59000 735000 500000 401000 1439000 1004000 1064000 8780000 0 -132000 -69000 1059000 927000 188000 333000 -12000 -4000 -9000000 0 -333000 -188000 -1456000 -1273000 7000 0 0 1000 0 515000 438000 0.5 0.5 579000 2140000 83367000 83267000 722000 721000 17899000 10796000 101988000 94784000 49228000 47661000 2505000 2520000 -78000 17000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the three month period ended March 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Restricted<br/> Stock<br/> Awards/Units</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average&#160;Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(8,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>27,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.97</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The following table summarizes stock option activity for the three month period ended March 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock<br/> Options</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life&#160;(in<br/> Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>614,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.94</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>617,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.85</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercisable at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.74</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.69</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The following table sets forth the computation of basic and diluted earnings per share for the three month periods ended March 31, 2016 and 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>Three&#160;Months&#160;ended&#160;March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Net income attributable to American Shared Hospital Services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>51,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>128,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Weighted average common shares for basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,541,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,477,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Diluted effect of stock options and restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>49,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Weighted average common shares for diluted earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,541,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,526,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Diluted earnings per share <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div><strong>Note 5.</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>Fair Value of Financial Instruments</strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The estimated fair value of the Company&#8217;s assets and liabilities as of March 31, 2016 and December 31, 2015 were as follows (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div>March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,204</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,204</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div>December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The estimated fair value of the Company&#8217;s assets and liabilities as of March 31, 2016 and December 31, 2015 were as follows (in thousands):</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Carrying<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div>March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,190</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,769</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,204</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,321</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,204</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="39%"> <div>December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Investment in equity securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,259</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,744</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,525</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.75in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="72"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">Note 6.</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">Repurchase of Common Stock</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2016 or 2015. There are approximately 72,000 shares remaining under this repurchase authorization.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.75in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="72"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">Note 7.</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">Income Taxes</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three month periods ended March 31, 2016 and 2015 by applying the actual effective tax rates to income reported within the condensed consolidated financial statements through those periods.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 5541000 5477000 0 49000 5541000 5526000 579000 579000 0.0046 2190000 579000 2769000 2838000 2259000 579000 8204000 9525000 8204000 9525000 2190000 2259000 2190000 0 0 2259000 0 0 579000 579000 0 0 579000 0 0 579000 2769000 2838000 2190000 0 579000 2259000 0 579000 8321000 9744000 0 0 8321000 0 0 9744000 8321000 9744000 0 0 8321000 0 0 9744000 1000000 72000 100000 100000 10000000 10000000 5364000 5364000 5364000 5364000 -108000 617000 617000 880000 750000 1630000 7900000 1000000 6700000 1137000 145000 80000 67000 72000 614000 2.85 2.86 3000 0 0 617000 82000 1.90 0 0 2.74 P2Y8M8D P5Y1M6D P4Y10M10D P6Y11M8D 3000 32000 8000 0 27000 0 1.97 1.89 1.89 0 0 0 7000 0 2.58 97000 88000 1137000 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="left"></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div>Note 1.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Basis of Presentation</div> </td> </tr> </table> &#160;<font style="FONT-SIZE: 10pt">&#160;</font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services&#8217; consolidated financial position as of March 31, 2016 and the results of its operations for the three month periods ended March 31, 2016 and 2015, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2015 have been derived from audited consolidated financial statements.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2015 included in the Company&#8217;s 10-K filed with the Securities and Exchange Commission.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the &#8220;Company&#8221;) and its subsidiaries as follows: The Company wholly-owns the subsidiaries OR21, Inc. (&#8220;OR21 LLC&#8221;), MedLeader.com, Inc. (&#8220;MedLeader&#8221;), PBRT Orlando, LLC (&#8220;Orlando&#8221;) and American Shared Radiosurgery Services (&#8220;ASRS&#8221;). The Company is also the majority owner of Long Beach Equipment, LLC (&#8220;LBE&#8221;). ASRS is the majority-owner of GK Financing, LLC (&#8220;GKF&#8221;) which wholly-owns the subsidiaries GK Financing U.K., Limited (&#8220;GKUK&#8221;), and Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;). GKF is also the majority-owner of the subsidiaries Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;) and Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of March 31, 2016 in the states of Arkansas, California, Oregon, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (&#8220;IMRT&#8221;), Image Guided Radiation Therapy (&#8220;IGRT&#8221;) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California and Orlando, Florida; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. Orlando treated its first patient in April 2016. GKPeru is expected to begin operation in mid-2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company continues to develop its design and business model for &#8220;The Operating Room for the 21st Century&#8221; SM (&#8220;OR21&#8221; <sup style="font-style:normal">SM</sup>), through its <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% owned OR21, LLC. The remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 50</font>% is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses and other healthcare workers. This subsidiary is not operational at this time.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Based on the guidance provided in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 280 <i>Segment Reporting</i> (&#8220;ASC 280&#8221;), the Company has analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there is one reportable segment, Medical Services Revenue. The Company provides Gamma Knife and IGRT equipment to seventeen hospitals in the United States as of March 31, 2016. These seventeen locations operate under different subsidiaries of the Company, but offer the same service, radiosurgery and radiation therapy. The operating results of the subsidiaries are reviewed by the Company&#8217;s Chief Executive Officer and Chief Financial Officer, who are also deemed the Company&#8217;s Chief Operating Decision Makers (&#8220;CODMs&#8221;) and this is done in conjunction with all of the subsidiaries and locations.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">On January 14, 2016, the Company entered into a definitive lease agreement for financing of its MEVION S250 at UF Health Cancer Center at Orlando Health. The proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,900,000</font> received to date, from this financing of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,400,000</font></font></font>, were used to pay-down the $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,000,000</font> in Promissory Notes (the &#8220;Notes&#8221;) with four members of the Company&#8217;s Board of Directors, reimburse the Company for freight costs associated with the MEVION S250, and to fund one of the remaining milestone payments for the MEVION S250 of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,700,000</font>. Total proceeds from capital lease financing for reimbursement of payments for acquisition of equipment, were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,137,000</font>.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Based on the guidance provided in accordance with ASC 405 <i>Extinguishment of Liabilities</i> (&#8220;ASC 405&#8221;) and ASC 470 <i>Debt Modifications and Extinguishments</i> (&#8220;ASC 470&#8221;), the pay-down of the Notes is considered an extinguishment of debt and, as such, the difference between the net carrying amount of the Notes and the costs of extinguishment were recognized as a loss on the Company&#8217;s condensed consolidated Statements of Operations. For the three month period ended March 31, 2016, the loss on early extinguishment of debt was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">108,000</font>. The Notes were issued with common stock warrants with an estimated fair value of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">145,000</font>. The unamortized balance of the discount on the Notes, of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80,000</font>, and deferred fees incurred from the issuance of the Note of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">28,000</font>, were recorded as loss on early extinguishment.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In May 2014, the Financial Accounting Standards Board &#8220;(FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i> Revenue from Contracts with Customers</i> (Topic 606), (&#8220;ASU 2014-09&#8221;), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in United States Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) when it becomes effective. The new standard is effective for the Company for annual reporting periods beginning after December 15, 2017. Early application is permitted for reporting periods beginning after December 15, 2016. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In August 2014, FASB issued ASU No. 2014-15, <i>Disclosure of Uncertainties About an Entity&#8217;s Ability to Continue as a Going Concern</i> (&#8220;ASU 2014-15&#8221;), which provides guidance on determining when and how to disclose going-concern uncertainties in financial statements. The new standard requires management to perform interim and annual assessments of an entity&#8217;s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity&#8217;s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is currently evaluating the impact of this update on future disclosures concerning its liquidity position.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In January 2015, the FASB issued ASU No. 2015-01, <i>Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items</i> (&#8220;ASU 2015-01&#8221;), which eliminates from GAAP the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with International Accounting Standards (&#8220;IAS&#8221;) 1<i>, Presentation of Financial Statements</i>, which prohibits the presentation and disclosure of extraordinary items. The new standard was effective for the Company on January 1, 2016. The standard permits the use of either the retrospective or prospective application. The Company adopted ASU 2015-01 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In February 2015, the FASB issued ASU No. 2015-02, <i>Consolidation (Topic 810): Amendments to the Consolidation Analysis</i> (&#8220;ASU 2015-02&#8221;), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard was effective for the Company on January 1, 2016. The Company adopted ASU 2015-02 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In April 2015, the FASB issued ASU No. 2015-03, <i>Interest&#151;Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</i> (&#8220;ASU 2015-03&#8221;), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard was effective for the Company on January 1, 2016.&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company adopted ASU 2015-03 on January 1, 2016, on a retrospective basis. Debt issuance costs that were previously recorded as other assets on the Company&#8217;s condensed consolidated Balance Sheets were reclassified as an offset to the respective debt instrument for which they were derived. As of March 31, 2016 and December 31, 2015, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">67,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">72,000</font> were reclassified from current and noncurrent other assets to current and noncurrent debt, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In January 2016, the FASB issued ASU No. 2016-01 <i>Recognition and Measurement of Financial Assets and Financial Liabilities</i> (&#8220;ASU 2016-01&#8221;) which requires equity investments, except those accounted for under the equity method of accounting or those that result in consolidation of the investee, to be measured at fair value with changes in fair value recognized in net income. The new guidance is effective for the Company on January 1, 2018. Early adoption is permitted. The standard permits the use of cumulative-effect transition method. The Company is evaluating the effect that ASU 2016-01 will have on its consolidated financial statements and related disclosures.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In February 2016, the FASB issued ASU No. 2016-02 <i>Leases</i> (&#8220;ASU 2016-02&#8221;), which requires lessees to recognize, for all leases, at the commencement date, a lease liability and a right-of-use asset. Under the new guidance, lessor accounting is largely unchanged. The new guidance is effective for the Company on January 1, 2019. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-02 will have on its consolidated financial statements and related disclosures.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In March 2016, the FASB issued ASU No. 2016-09 <i>Compensation &#150; Stock Compensation</i> <i>(Topic 718)</i> (&#8220;ASU 2016-09&#8221;) which changes five aspects of accounting for share-based payment award transactions including 1) accounting for income taxes; 2) classification of excess tax benefits on the statement of cash flows; 3) forfeitures; 4) minimum statutory tax withholding requirements; 5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. The new guidance is effective for the Company for interim and annual periods beginning after December 15, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-09 will have on its consolidated financial statements and related disclosures.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.75in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="72"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Note 2.</font></strong></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Per Share Amounts</font></strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding. The computation for the three month periods ended March 31, 2016 and 2015 excluded approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 617,000</font></font> of the Company&#8217;s stock options because the exercise price of the options was higher than the average market price during those periods.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table sets forth the computation of basic and diluted earnings per share for the three month periods ended March 31, 2016 and 2015:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>Three&#160;Months&#160;ended&#160;March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Net income attributable to American Shared Hospital Services</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>51,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>128,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Weighted average common shares for basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,541,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,477,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Diluted effect of stock options and restricted stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>49,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Weighted average common shares for diluted earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,541,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5,526,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Basic earnings per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Diluted earnings per share <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>0.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 3.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Stock-based Compensation</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">On June 2, 2010, the Company&#8217;s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the &#8220;2006 Plan&#8221;). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the &#8220;Plan&#8221;) and increased the number of shares of the Company&#8217;s common stock reserved for issuance under the Plan by an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 880,000</font> shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font> shares to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,630,000</font> shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company&#8217;s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company&#8217;s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">Stock-based compensation expense associated with the Company&#8217;s stock-based options to employees is calculated using the Black-Scholes valuation model. The Company&#8217;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company&#8217;s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company&#8217;s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect, for the Company&#8217;s options and restricted stock awards, in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">59,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">36,000</font> is reflected in net income for the three month periods ended March 31, 2016 and 2015. At March 31, 2016, there was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">440,000</font> of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately four years.</font></div> &#160; <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the three month period ended March 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Restricted<br/> Stock<br/> Awards/Units</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average&#160;Fair<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic<br/> Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.58</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(8,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>27,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.97</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes stock option activity for the three month period ended March 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock<br/> Options</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Grant&#160;Date<br/> Weighted-<br/> Average<br/> Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Life&#160;(in<br/> Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at January 1, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>614,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>5.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.94</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Outstanding at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>617,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.85</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Exercisable at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>82,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.74</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.69</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 4.</div> </td> <td style="TEXT-ALIGN: justify"> <div>Investment in Equity Securities</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of March 31, 2016 and December 31, 2015 the Company had a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">579,000</font></font> investment in the common stock of Mevion Medical Systems, Inc. (&#8220;Mevion&#8221;), formerly Still River Systems, Inc., representing an approximate <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.46</font>% interest in Mevion. The Company accounts for this investment under the cost method.</div> <font style="FONT-WEIGHT: normal">&#160;</font> <font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">The Company carries its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable.&#160;During the period ended December 31, 2015, the Company determined that its investment was other than temporarily impaired. In determining the fair value of the Company&#8217;s common stock in Mevion,&#160;the Company engaged a third party expert to review and corroborate its assessment of the fair value of the investment. The third party utilized the market approach and an option waterfall model calibrated to Mevion&#8217;s last round of funding. Each equity class was examined and priced according to its liquidation preferences. The fair value of the Company&#8217;s investment in Mevion, as of December 31, 2015, was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">579,000</font> with an impairment loss for the year then ended of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,140,000</font>.</font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The Company reviewed this investment at March 31, 2016 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room proton beam radiation therapy (&#8220;PBRT&#8221;) system. Based on its analysis, the Company determined no additional impairment needs to be recognized as of March 31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal">The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (&#8220;Barnes-Jewish Hospital&#8221;), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (&#8220;Ackerman Cancer Center&#8221;), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (&#8220;Robert Wood Johnson&#8221;), started in May 2015. The Company&#8217;s first MEVION S250 treated its first patient on April 6, 2016.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 59000 36000 8400000 440000 28000 EX-101.SCH 6 ams-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Per Share Amounts link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Investment in Equity Securities link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Repurchase of Common Stock link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Per Share Amounts (Tables) link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Per Share Amounts (Details) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Per Share Amounts (Details Textual) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Stock-based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Stock-based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Investment in Equity Securities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Repurchase of Common Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ams-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ams-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ams-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 ams-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document And Entity Information - shares
 3 Months Ended
Mar. 31, 2016
May. 01, 2016
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2016  
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q1  
Entity Registrant Name AMERICAN SHARED HOSPITAL SERVICES  
Entity Central Index Key 0000744825  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol AMS  
Entity Common Stock, Shares Outstanding   5,364,000
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 2,140,000 $ 2,209,000
Restricted cash 50,000 50,000
Accounts receivable, net of allowance for doubtful accounts of $100,000 at March 31, 2016 and $100,000 at December 31, 2015 3,557,000 3,038,000
Other receivables 88,000 107,000
Prepaid expenses and other current assets 531,000 570,000
Total current assets 6,366,000 5,974,000
Property and equipment:    
Medical equipment and facilities 83,367,000 83,267,000
Office equipment 722,000 721,000
Deposits and construction in progress 17,899,000 10,796,000
Property and equipment 101,988,000 94,784,000
Accumulated depreciation and amortization (49,228,000) (47,661,000)
Net property and equipment 52,760,000 47,123,000
Investment in equity securities 579,000 579,000
Other assets 382,000 366,000
Total assets 60,087,000 54,042,000
Current liabilities:    
Accounts payable 531,000 375,000
Employee compensation and benefits 198,000 156,000
Other accrued liabilities 1,052,000 1,162,000
Current portion of long-term debt 2,637,000 2,641,000
Current portion of obligations under capital leases 4,767,000 4,331,000
Total current liabilities 9,185,000 8,665,000
Long-term debt, less current portion 5,567,000 6,884,000
Long-term capital leases, less current portion 15,697,000 9,190,000
Deferred revenue, less current portion 689,000 719,000
Deferred income taxes 3,468,000 3,404,000
Shareholders' equity:    
Common stock (10,000,000 authorized; 5,364,000 shares issued and outstanding at March 31, 2016 and December 31, 2015) 10,376,000 10,376,000
Additional paid-in capital 5,793,000 5,734,000
Retained earnings 4,071,000 4,020,000
Total equity-American Shared Hospital Services 20,240,000 20,130,000
Non-controlling interest in subsidiary 5,241,000 5,050,000
Total shareholders' equity 25,481,000 25,180,000
Total liabilities and shareholders' equity $ 60,087,000 $ 54,042,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Allowance for doubtful accounts (in dollars) $ 100,000 $ 100,000
Common stock, shares authorized 10,000,000 10,000,000
Common stock, shares issued 5,364,000 5,364,000
Common stock, shares outstanding 5,364,000 5,364,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue:    
Medical services revenue $ 4,238,000 $ 4,117,000
Costs of revenue:    
Maintenance and supplies 244,000 333,000
Depreciation and amortization 1,562,000 1,505,000
Other direct operating costs 699,000 682,000
Costs of revenue 2,505,000 2,520,000
Gross Margin 1,733,000 1,597,000
Selling and administrative expense 949,000 821,000
Interest expense 285,000 320,000
Operating income 499,000 456,000
(Loss) on early extinguishment of debt (108,000) 0
Interest and other income 5,000 6,000
Income before income taxes 396,000 462,000
Income tax expense 64,000 130,000
Net income 332,000 332,000
Less: Net income attributable to non-controlling interest (281,000) (204,000)
Net income attributable to American Shared Hospital Services $ 51,000 $ 128,000
Net income per share:    
Earnings per common share - basic $ 0.01 $ 0.02
Earnings per common share - diluted $ 0.01 $ 0.02
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Sub-Total ASHS [Member]
Non-controlling Interest [Member]
Balances at Dec. 31, 2014 $ 26,154,000 $ 10,376,000 $ 5,508,000 $ 5,542,000 $ 21,426,000 $ 4,728,000
Balances (in shares) at Dec. 31, 2014   5,361,000        
Stock based compensation expense 226,000 $ 0 226,000 0 226,000 0
Stock based compensation expense (in shares)   3,000        
Non-controlling interest investment in subsidiaries 46,000 $ 0 0 0 0 46,000
Cash distributions to non-controlling interests (670,000) 0 0 0 0 (670,000)
Net (loss) income (576,000) 0 0 (1,522,000) (1,522,000) 946,000
Balances at Dec. 31, 2015 25,180,000 $ 10,376,000 5,734,000 4,020,000 20,130,000 5,050,000
Balances (in shares) at Dec. 31, 2015   5,364,000        
Stock based compensation expense 59,000 $ 0 59,000 0 59,000 0
Stock based compensation expense (in shares)   0        
Non-controlling interest investment in subsidiaries 7,000 $ 0 0 0 0 7,000
Cash distributions to non-controlling interests (97,000) 0 0 0 0 (97,000)
Net (loss) income 332,000 0 0 51,000 51,000 281,000
Balances at Mar. 31, 2016 $ 25,481,000 $ 10,376,000 $ 5,793,000 $ 4,071,000 $ 20,240,000 $ 5,241,000
Balances (in shares) at Mar. 31, 2016   5,364,000        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Operating activities:    
Net income $ 332,000 $ 332,000
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 1,574,000 1,517,000
(Gain) on sale of assets (1,000) 0
Loss on early extinguishment of debt 108,000 0
Deferred income tax 64,000 0
Stock-based compensation expense 59,000 36,000
Other non-cash items 4,000 12,000
Changes in operating assets and liabilities:    
Receivables (500,000) (735,000)
Prepaid expenses and other assets 22,000 9,000
Customer deposits/deferred revenue (78,000) 17,000
Accounts payable and accrued liabilities 136,000 141,000
Net cash from operating activities 1,720,000 1,329,000
Investing activities:    
Payment for purchase of property and equipment (333,000) (188,000)
Net cash used in investing activities (333,000) (188,000)
Financing activities:    
Principal payments on long-term debt (1,439,000) (401,000)
Principal payments on capital leases (1,064,000) (1,004,000)
Proceeds from certificate of deposit 0 9,000,000
Payments on line of credit 0 (8,780,000)
Capital contributions from non-controlling interests 7,000 0
Distributions to non-controlling interests (97,000) (88,000)
Proceeds from capital lease financing for reimbursement of payments for acquisition of equipment 1,137,000 0
Net cash used in financing activities (1,456,000) (1,273,000)
Net change in cash and cash equivalents (69,000) (132,000)
Cash and cash equivalents at beginning of period 2,209,000 1,059,000
Cash and cash equivalents at end of period 2,140,000 927,000
Supplemental cash flow disclosure:    
Interest 515,000 438,000
Income taxes (refunds) 96,000 (5,000)
Schedule of non-cash investing and financing activities    
Acquisition of equipment with capital lease financing $ 6,870,000 $ 1,160,000
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
Basis of Presentation
 3 Months Ended
Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1.
Basis of Presentation
  
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of March 31, 2016 and the results of its operations for the three month periods ended March 31, 2016 and 2015, which results are not necessarily indicative of results on an annualized basis. Consolidated balance sheet amounts as of December 31, 2015 have been derived from audited consolidated financial statements.
 
These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2015 included in the Company’s 10-K filed with the Securities and Exchange Commission.
 
These condensed consolidated financial statements include the accounts of American Shared Hospital Services (the “Company”) and its subsidiaries as follows: The Company wholly-owns the subsidiaries OR21, Inc. (“OR21 LLC”), MedLeader.com, Inc. (“MedLeader”), PBRT Orlando, LLC (“Orlando”) and American Shared Radiosurgery Services (“ASRS”). The Company is also the majority owner of Long Beach Equipment, LLC (“LBE”). ASRS is the majority-owner of GK Financing, LLC (“GKF”) which wholly-owns the subsidiaries GK Financing U.K., Limited (“GKUK”), and Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”). GKF is also the majority-owner of the subsidiaries Albuquerque GK Equipment, LLC (“AGKE”) and Jacksonville GK Equipment, LLC (“JGKE”).
 
The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to seventeen medical centers as of March 31, 2016 in the states of Arkansas, California, Oregon, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas, and Washington.
 
The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.
 
The Company formed the subsidiaries GKUK and GKPeru, for the purposes of expanding its business internationally into the United Kingdom and Peru; LBE and Orlando to provide proton beam therapy services in Long Beach, California and Orlando, Florida; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida. AGKE began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011. Orlando treated its first patient in April 2016. GKPeru is expected to begin operation in mid-2016. GKUK is inactive and LBE is not expected to generate revenue within the next two years.
 
The Company continues to develop its design and business model for “The Operating Room for the 21st Century” SM (“OR21” SM), through its 50% owned OR21, LLC. The remaining 50% is owned by an architectural design company. OR21 is not expected to generate significant revenue within the next two years.
 
MedLeader was formed to provide continuing medical education online and through videos for doctors, nurses and other healthcare workers. This subsidiary is not operational at this time.
 
Based on the guidance provided in accordance with Accounting Standards Codification (“ASC”) 280 Segment Reporting (“ASC 280”), the Company has analyzed its subsidiaries which are all in the business of leasing radiosurgery and radiation therapy equipment to healthcare providers, and concluded there is one reportable segment, Medical Services Revenue. The Company provides Gamma Knife and IGRT equipment to seventeen hospitals in the United States as of March 31, 2016. These seventeen locations operate under different subsidiaries of the Company, but offer the same service, radiosurgery and radiation therapy. The operating results of the subsidiaries are reviewed by the Company’s Chief Executive Officer and Chief Financial Officer, who are also deemed the Company’s Chief Operating Decision Makers (“CODMs”) and this is done in conjunction with all of the subsidiaries and locations.
 
On January 14, 2016, the Company entered into a definitive lease agreement for financing of its MEVION S250 at UF Health Cancer Center at Orlando Health. The proceeds of $7,900,000 received to date, from this financing of approximately $8,400,000, were used to pay-down the $1,000,000 in Promissory Notes (the “Notes”) with four members of the Company’s Board of Directors, reimburse the Company for freight costs associated with the MEVION S250, and to fund one of the remaining milestone payments for the MEVION S250 of approximately $6,700,000. Total proceeds from capital lease financing for reimbursement of payments for acquisition of equipment, were approximately $1,137,000. 
 
Based on the guidance provided in accordance with ASC 405 Extinguishment of Liabilities (“ASC 405”) and ASC 470 Debt Modifications and Extinguishments (“ASC 470”), the pay-down of the Notes is considered an extinguishment of debt and, as such, the difference between the net carrying amount of the Notes and the costs of extinguishment were recognized as a loss on the Company’s condensed consolidated Statements of Operations. For the three month period ended March 31, 2016, the loss on early extinguishment of debt was $108,000. The Notes were issued with common stock warrants with an estimated fair value of $145,000. The unamortized balance of the discount on the Notes, of $80,000, and deferred fees incurred from the issuance of the Note of approximately $28,000, were recorded as loss on early extinguishment.
 
In May 2014, the Financial Accounting Standards Board “(FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASU 2014-09”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in United States Generally Accepted Accounting Principles (“GAAP”) when it becomes effective. The new standard is effective for the Company for annual reporting periods beginning after December 15, 2017. Early application is permitted for reporting periods beginning after December 15, 2016. The standard permits the use of either the retrospective or cumulative effect transition method. In July 2015, the FASB voted to delay the effective date of this standard until the first quarter of 2018. The Company is evaluating the effect that ASU 2014-09 will have on its consolidated financial statements and related disclosures and has not yet selected a transition method.
 
In August 2014, FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”), which provides guidance on determining when and how to disclose going-concern uncertainties in financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is currently evaluating the impact of this update on future disclosures concerning its liquidity position.
 
In January 2015, the FASB issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items (“ASU 2015-01”), which eliminates from GAAP the concept of extraordinary items and requires that an entity separately classify, present, and disclose extraordinary events and transactions. This ASU will also align more closely GAAP income statement presentation guidance with International Accounting Standards (“IAS”) 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The new standard was effective for the Company on January 1, 2016. The standard permits the use of either the retrospective or prospective application. The Company adopted ASU 2015-01 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.
 
In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”), which is intended to improve targeted areas of consolidation guidance for legal entities. The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB ASC and improves current GAAP. The new standard was effective for the Company on January 1, 2016. The Company adopted ASU 2015-02 on January 1, 2016 and the adoption did not have a material impact on the condensed consolidated financial statements and related disclosures.
 
In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability, be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The new standard was effective for the Company on January 1, 2016. 
 
The Company adopted ASU 2015-03 on January 1, 2016, on a retrospective basis. Debt issuance costs that were previously recorded as other assets on the Company’s condensed consolidated Balance Sheets were reclassified as an offset to the respective debt instrument for which they were derived. As of March 31, 2016 and December 31, 2015, $67,000 and $72,000 were reclassified from current and noncurrent other assets to current and noncurrent debt, respectively.
 
In January 2016, the FASB issued ASU No. 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”) which requires equity investments, except those accounted for under the equity method of accounting or those that result in consolidation of the investee, to be measured at fair value with changes in fair value recognized in net income. The new guidance is effective for the Company on January 1, 2018. Early adoption is permitted. The standard permits the use of cumulative-effect transition method. The Company is evaluating the effect that ASU 2016-01 will have on its consolidated financial statements and related disclosures.
 
In February 2016, the FASB issued ASU No. 2016-02 Leases (“ASU 2016-02”), which requires lessees to recognize, for all leases, at the commencement date, a lease liability and a right-of-use asset. Under the new guidance, lessor accounting is largely unchanged. The new guidance is effective for the Company on January 1, 2019. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-02 will have on its consolidated financial statements and related disclosures.
 
In March 2016, the FASB issued ASU No. 2016-09 Compensation – Stock Compensation (Topic 718) (“ASU 2016-09”) which changes five aspects of accounting for share-based payment award transactions including 1) accounting for income taxes; 2) classification of excess tax benefits on the statement of cash flows; 3) forfeitures; 4) minimum statutory tax withholding requirements; 5) classification of employee taxes paid on the statement of cash flows when an employer withholds shares for tax-withholding purposes. The new guidance is effective for the Company for interim and annual periods beginning after December 15, 2016. Early adoption is permitted. The Company is evaluating the effect that ASU 2016-09 will have on its consolidated financial statements and related disclosures.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per Share Amounts
 3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 2.
Per Share Amounts
 
Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding. The computation for the three month periods ended March 31, 2016 and 2015 excluded approximately 617,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during those periods.
 
The following table sets forth the computation of basic and diluted earnings per share for the three month periods ended March 31, 2016 and 2015:
 
 
 
Three Months ended March 31,
 
 
 
2016
 
2015
 
Net income attributable to American Shared Hospital Services
 
$
51,000
 
$
128,000
 
 
 
 
 
 
 
 
 
Weighted average common shares for basic earnings per share
 
 
5,541,000
 
 
5,477,000
 
Diluted effect of stock options and restricted stock
 
 
-
 
 
49,000
 
Weighted average common shares for diluted earnings per share
 
 
5,541,000
 
 
5,526,000
 
 
 
 
 
 
 
 
 
Basic earnings per share
 
$
0.01
 
$
0.02
 
Diluted earnings per share
 
$
0.01
 
$
0.02
 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-based Compensation
 3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 3.
Stock-based Compensation
 
On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. On June 16, 2015, the Company’s shareholders approved an amendment and restatement of the Plan in order to extend the term of the Plan by two years.
 
Stock-based compensation expense associated with the Company’s stock-based options to employees is calculated using the Black-Scholes valuation model. The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award (requisite service period), usually the vesting period. Accordingly, stock-based compensation cost before income tax effect, for the Company’s options and restricted stock awards, in the amount of $59,000 and $36,000 is reflected in net income for the three month periods ended March 31, 2016 and 2015. At March 31, 2016, there was approximately $440,000 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. This cost is expected to be recognized over a period of approximately four years.
 
The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the three month period ended March 31, 2016:
  
 
 
Restricted
Stock
Awards/Units
 
Grant Date
Weighted-
Average Fair
Value
 
Intrinsic
Value
 
Outstanding at January 1, 2016
 
 
3,000
 
$
2.58
 
$
-
 
Granted
 
 
32,000
 
$
1.89
 
$
-
 
Vested
 
 
(8,000)
 
$
1.89
 
$
-
 
Forfeited
 
 
-
 
$
-
 
$
-
 
Outstanding at March 31, 2016
 
 
27,000
 
$
1.97
 
$
7000
 
 
The following table summarizes stock option activity for the three month period ended March 31, 2016:
 
 
 
Stock
Options
 
Grant Date
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Life (in
Years)
 
Outstanding at January 1, 2016
 
 
614,000
 
$
2.86
 
 
5.10
 
Granted
 
 
3,000
 
$
1.90
 
 
6.94
 
Exercised
 
 
-
 
$
-
 
 
-
 
Forfeited
 
 
-
 
$
-
 
 
-
 
Outstanding at March 31, 2016
 
 
617,000
 
$
2.85
 
 
4.86
 
Exercisable at March 31, 2016
 
 
82,000
 
$
2.74
 
 
2.69
 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
Investment in Equity Securities
 3 Months Ended
Mar. 31, 2016
Investments, All Other Investments [Abstract]  
Cost-method Investments, Description [Text Block]
Note 4.
Investment in Equity Securities
 
As of March 31, 2016 and December 31, 2015 the Company had a $579,000 investment in the common stock of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, Inc., representing an approximate 0.46% interest in Mevion. The Company accounts for this investment under the cost method.
 
The Company carries its investment in Mevion at cost and reviews it for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable. During the period ended December 31, 2015, the Company determined that its investment was other than temporarily impaired. In determining the fair value of the Company’s common stock in Mevion, the Company engaged a third party expert to review and corroborate its assessment of the fair value of the investment. The third party utilized the market approach and an option waterfall model calibrated to Mevion’s last round of funding. Each equity class was examined and priced according to its liquidation preferences. The fair value of the Company’s investment in Mevion, as of December 31, 2015, was approximately $579,000 with an impairment loss for the year then ended of $2,140,000.
 
The Company reviewed this investment at March 31, 2016 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room proton beam radiation therapy (“PBRT”) system. Based on its analysis, the Company determined no additional impairment needs to be recognized as of March 31, 2016.
 
The first MEVION S250, located at Barnes-Jewish Hospital in St. Louis, MO (“Barnes-Jewish Hospital”), treated its first patient on December 19, 2013. The second MEVION S250, located at the Ackerman Cancer Center in Jacksonville, Florida (“Ackerman Cancer Center”), treated its first patient in April 2015. The third MEVION S250, located at Robert Wood Johnson University Hospital in New Brunswick, New Jersey (“Robert Wood Johnson”), started in May 2015. The Company’s first MEVION S250 treated its first patient on April 6, 2016.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value of Financial Instruments
 3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 5.
Fair Value of Financial Instruments
 
The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. The estimated fair value of the Company’s assets and liabilities as of March 31, 2016 and December 31, 2015 were as follows (in thousands):
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Carrying
Value
 
March 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,190
 
$
-
 
$
-
 
$
2,190
 
$
2,190
 
Investment in equity securities
 
 
-
 
 
-
 
 
579
 
 
579
 
 
579
 
Total
 
$
2,190
 
$
-
 
$
579
 
$
2,769
 
$
2,769
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
-
 
$
8,321
 
$
8,321
 
$
8,204
 
Total
 
$
-
 
$
-
 
$
8,321
 
$
8,321
 
$
8,204
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,259
 
$
-
 
$
-
 
$
2,259
 
$
2,259
 
Investment in equity securities
 
 
-
 
 
-
 
 
579
 
 
579
 
 
579
 
Total
 
$
2,259
 
$
-
 
$
579
 
$
2,838
 
$
2,838
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
-
 
$
9,744
 
$
9,744
 
$
9,525
 
Total
 
$
-
 
$
-
 
$
9,744
 
$
9,744
 
$
9,525
 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
Repurchase of Common Stock
 3 Months Ended
Mar. 31, 2016
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 6.
Repurchase of Common Stock
 
In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008. There were no shares repurchased in 2016 or 2015. There are approximately 72,000 shares remaining under this repurchase authorization.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
Income Taxes
 3 Months Ended
Mar. 31, 2016
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
Note 7.
Income Taxes
 
We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annualized effective income tax rate expected to be applicable for the full fiscal year. However, when a reliable estimate of the annualized effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the results of operations reported within the year-to-date periods. Our effective income tax rate is highly influenced by relative income or losses reported and the amount of the nondeductible stock-based compensation associated with grants of our common stock options and historically from the results of foreign operations. A small change in estimated annual pretax income (loss) can produce a significant variance in the annualized effective income tax rate given the expected amount of these items. As a result, we have computed our provision for income taxes for the three month periods ended March 31, 2016 and 2015 by applying the actual effective tax rates to income reported within the condensed consolidated financial statements through those periods.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per Share Amounts (Tables)
 3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table sets forth the computation of basic and diluted earnings per share for the three month periods ended March 31, 2016 and 2015:
 
 
 
Three Months ended March 31,
 
 
 
2016
 
2015
 
Net income attributable to American Shared Hospital Services
 
$
51,000
 
$
128,000
 
 
 
 
 
 
 
 
 
Weighted average common shares for basic earnings per share
 
 
5,541,000
 
 
5,477,000
 
Diluted effect of stock options and restricted stock
 
 
-
 
 
49,000
 
Weighted average common shares for diluted earnings per share
 
 
5,541,000
 
 
5,526,000
 
 
 
 
 
 
 
 
 
Basic earnings per share
 
$
0.01
 
$
0.02
 
Diluted earnings per share
 
$
0.01
 
$
0.02
 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-based Compensation (Tables)
 3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
The following table summarizes unvested restricted stock awards, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, for the three month period ended March 31, 2016:
  
 
 
Restricted
Stock
Awards/Units
 
Grant Date
Weighted-
Average Fair
Value
 
Intrinsic
Value
 
Outstanding at January 1, 2016
 
 
3,000
 
$
2.58
 
$
-
 
Granted
 
 
32,000
 
$
1.89
 
$
-
 
Vested
 
 
(8,000)
 
$
1.89
 
$
-
 
Forfeited
 
 
-
 
$
-
 
$
-
 
Outstanding at March 31, 2016
 
 
27,000
 
$
1.97
 
$
7000
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
The following table summarizes stock option activity for the three month period ended March 31, 2016:
 
 
 
Stock
Options
 
Grant Date
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Life (in
Years)
 
Outstanding at January 1, 2016
 
 
614,000
 
$
2.86
 
 
5.10
 
Granted
 
 
3,000
 
$
1.90
 
 
6.94
 
Exercised
 
 
-
 
$
-
 
 
-
 
Forfeited
 
 
-
 
$
-
 
 
-
 
Outstanding at March 31, 2016
 
 
617,000
 
$
2.85
 
 
4.86
 
Exercisable at March 31, 2016
 
 
82,000
 
$
2.74
 
 
2.69
 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value of Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The estimated fair value of the Company’s assets and liabilities as of March 31, 2016 and December 31, 2015 were as follows (in thousands):
 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Carrying
Value
 
March 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,190
 
$
-
 
$
-
 
$
2,190
 
$
2,190
 
Investment in equity securities
 
 
-
 
 
-
 
 
579
 
 
579
 
 
579
 
Total
 
$
2,190
 
$
-
 
$
579
 
$
2,769
 
$
2,769
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
-
 
$
8,321
 
$
8,321
 
$
8,204
 
Total
 
$
-
 
$
-
 
$
8,321
 
$
8,321
 
$
8,204
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
2,259
 
$
-
 
$
-
 
$
2,259
 
$
2,259
 
Investment in equity securities
 
 
-
 
 
-
 
 
579
 
 
579
 
 
579
 
Total
 
$
2,259
 
$
-
 
$
579
 
$
2,838
 
$
2,838
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Debt obligations
 
$
-
 
$
-
 
$
9,744
 
$
9,744
 
$
9,525
 
Total
 
$
-
 
$
-
 
$
9,744
 
$
9,744
 
$
9,525
 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.4.0.3
Basis of Presentation (Details Textual) - USD ($)
 3 Months Ended
Jan. 14, 2016
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Debt obligations, Carrying Value   $ 8,204,000   $ 9,525,000
Payments to Acquire Property, Plant, and Equipment, Total   333,000 $ 188,000  
Loss on early extinguishment of debt   (108,000) $ 0  
Accounting Standards Update 2015-03 [Member]        
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets   67,000   $ 72,000
Notes Payable [Member]        
Debt Instrument, Face Amount   145,000    
Unamortized discount on Notes   80,000    
Deferred fees from issuance of Note   $ 28,000    
Mevion Medical Systems Inc [Member]        
Proceeds from Long-term Capital Lease Obligations $ 7,900,000      
Debt obligations, Carrying Value 8,400,000      
Repayments of Notes Payable 1,000,000      
Purchase Commitment, Remaining Minimum Amount Committed 6,700,000      
Payments to Acquire Property, Plant, and Equipment, Total $ 1,137,000      
OR21 LLC [Member]        
Equity Method Investment, Ownership Percentage   50.00%    
Architectural Design Company [Member]        
Equity Method Investment, Ownership Percentage   50.00%    
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per Share Amounts (Details) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Schedule Of Earnings Per Share Basic And Diluted [Line Items]    
Net income attributable to American Shared Hospital Services $ 51,000 $ 128,000
Weighted average common shares for basic earnings per share 5,541,000 5,477,000
Diluted effect of stock options and restricted stock 0 49,000
Weighted average common shares for diluted earnings per share 5,541,000 5,526,000
Basic earnings per share $ 0.01 $ 0.02
Diluted earnings per share $ 0.01 $ 0.02
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.4.0.3
Per Share Amounts (Details Textual) - shares
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 617,000 617,000
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-based Compensation (Details) - Restricted Stock Units (RSUs) [Member]
 3 Months Ended
Mar. 31, 2016
$ / shares
shares
Shareholders Equity [Line Items]  
Nonvested, Number of Options, Outstanding | shares 3,000
Nonvested, Number of Options, Granted | shares 32,000
Nonvested, Number of Options, Vested | shares (8,000)
Nonvested, Number of Options, Forfeited | shares 0
Nonvested, Number of Options, Outstanding | shares 27,000
Weighted Average Grant-Date Fair Value, Nonvested, Outstanding $ 2.58
Weighted Average Grant-Date Fair Value, Nonvested, Granted 1.89
Weighted Average Grant-Date Fair Value, Nonvested, Vested 1.89
Weighted Average Grant-Date Fair Value, Nonvested, Forfeited 0
Weighted Average Grant-Date Fair Value, Nonvested, Outstanding 1.97
Intrinsic Value, Outstanding 0
Intrinsic Value, Granted 0
Intrinsic Value, Vested 0
Intrinsic Value, Forfeited 0
Intrinsic Value, Outstanding $ 7,000
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-based Compensation (Details 1) - $ / shares
 3 Months Ended 12 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Schedule Of Share Based Compensation Stock Options Activity [Line Items]    
Number of Options, Beginning balance 614,000  
Number of Options, Granted 3,000  
Number of Options, Exercised 0  
Number of Options, Forfeited 0  
Number of Options, Ending balance 617,000 614,000
Number of Options, Exercisable 82,000  
Weighted Average Exercise Price, Beginning balance $ 2.86  
Weighted Average Exercise Price, Granted 1.90  
Weighted Average Exercise Price - Exercised 0  
Weighted Average Exercise Price, Forfeited 0  
Weighted Average Exercise Price, Ending balance 2.85 $ 2.86
Grant Date Weighted Average Exercise Price, Exercisable $ 2.74  
Weighted Average Remaining Contractual Life (Years), Balance 4 years 10 months 10 days 5 years 1 month 6 days
Weighted Average Remaining Contractual Life (Years), Granted 6 years 11 months 8 days  
Weighted Average Remaining Contractual Life (Years), Exercisable 2 years 8 months 8 days  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-based Compensation (Details Textual) - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Jun. 02, 2010
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated Share Based Compensation Expense $ 59,000 $ 36,000  
Incentive Compensation Plan [Member]      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Common Stock, Capital Shares Reserved for Future Issuance     880,000
Share-based Compensation, Compensation Cost Not yet Recognized $ 440,000    
Incentive Compensation Plan [Member] | Maximum [Member]      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Common Stock, Capital Shares Reserved for Future Issuance     1,630,000
Incentive Compensation Plan [Member] | Minimum [Member]      
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Common Stock, Capital Shares Reserved for Future Issuance     750,000
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.4.0.3
Investment in Equity Securities (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2015
Mar. 31, 2016
Schedule of Cost-method Investments [Line Items]    
Equity Method Investments $ 579,000 $ 579,000
Mevion Medical Systems Inc [Member]    
Schedule of Cost-method Investments [Line Items]    
Equity Method Investments 579,000 $ 579,000
Equity Method Investment, Ownership Percentage   0.46%
Investments, Fair Value Disclosure 579,000  
Other than Temporary Impairment Losses, Investments $ 2,140,000  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.4.0.3
Fair Value of Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Assets, Carrying Value:    
Cash, cash equivalents, restricted cash, Carrying Value $ 2,190 $ 2,259
Investment in equity securities, Carrying Value 579 579
Total, Carrying Value 2,769 2,838
Liabilities, Carrying Value    
Debt obligations, Carrying Value 8,204 9,525
Total, Carrying Value 8,204 9,525
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 2,190 2,259
Investment in equity securities, Fair Value 579 579
Total, Fair Value 2,769 2,838
Liabilities, Fair Value    
Debt obligations, Fair Value 8,321 9,744
Total, Fair Value 8,321 9,744
Fair Value, Inputs, Level 1 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 2,190 2,259
Investment in equity securities, Fair Value 0 0
Total, Fair Value 2,190 2,259
Liabilities, Fair Value    
Debt obligations, Fair Value 0 0
Total, Fair Value 0 0
Fair Value, Inputs, Level 2 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 0 0
Investment in equity securities, Fair Value 0 0
Total, Fair Value 0 0
Liabilities, Fair Value    
Debt obligations, Fair Value 0 0
Total, Fair Value 0 0
Fair Value, Inputs, Level 3 [Member]    
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 0 0
Investment in equity securities, Fair Value 579 579
Total, Fair Value 579 579
Liabilities, Fair Value    
Debt obligations, Fair Value 8,321 9,744
Total, Fair Value $ 8,321 $ 9,744
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
Repurchase of Common Stock (Details Textual) - shares
Mar. 31, 2016
Dec. 31, 2008
Equity, Class of Treasury Stock [Line Items]    
Stock Repurchase Program, Number of Shares Authorized to be Repurchased   1,000,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 72,000  
EXCEL 36 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
*R,\6QR003((=DV#RS^&'(]+/#JWVPN$(!(YHAR.0E6;N=D-TOK.5HQ'(DA/M M2TX@:TZ);D_O7'4"QRP0S*(=LT#I&<7.=QI30HI>=PDY:)& %NV@1<+/Q(DC MJI.>'V'(.8MD&8KV92B:"\QA>>0V15:B(O9[TR(G-Q)RHYW<:/(89.1\_1-A M#GZK)/SCZYM\?F/JD8(S%@ECT-)] MK^MIE^R@=:\&A^+#<-]/JMC?3BIUZ,?#=#ANYTV]^:37YY<]RMM&Z>8W4$L# M!!0 ( #U K$CI'9'6GP$ +$# 8 >&PO=V]R:W-H965T&ULA5/;;J,P$/T5RQ]0$T)VJX@@-:VJW8>5JC[L/CLP@%7;0VT3NG]? M7PA-HDA]P3/#.6?.^%).:-YL#^#(AY+:[FCOW+!ES-8]*&[O< #M_[1H%'<^ M-1VS@P'>1)*2+,^R'TQQH6E5QMJ+J4H!5= M[T*!525;>(U0H*U 30RT._JPVNZ+@(B OP(F>Q:3X/V ^!:2W\V.9L$"2*A= M4.!^.<(C2!F$?./W6?.K92">QR?UYSBM=W_@%AY1_A.-Z[W9C)(&6CY*]XK3 M+YA'V 3!&J6-7U*/UJ$Z42A1_".M0L=U2G_NLYEVFY#/A/R*P%*C:/.).UZ5 M!B=B!Q[.;K7UJQ615ZR8Q"ZP.P3)D^8!<&\^LT6^66+ M?7Y&S[^GKZ\*C!=O#J6U#AJ MES9OJ2ZW\R&/9_(%K\J!=_"'FTYH2P[H_,G&0VT1'7@3V=V&DMZ_GR61T+H0 M_O2Q25ZAM0O?OUQ="DRA27_#,<,Z9,[Z4$YIWVP,X\JFDMEO: M.S=L&+-U#XK;&QQ ^S\M&L6=3TW'[&" -Y&D),NS[(XI+C2MREA[-56)HY-" MPZLA=E2*FW\[D#AMZ8H>"V^BZUTHL*ID"Z\1"K05J(F!=DL?5YM=$1 1\$? M9$]B$KSO$=]#\JO9TBQ8 FU"PK<+P=X BF#D&_\,6M^M0S$T_BH_A*G]>[W MW,(3RK^B<;TWFU'20,M'Z=YP^@GS"+=!L$9IXY?4HW6HCA1*%/],J]!QG=*? M=3[3KA/RF9 OA([,QC=.GZJ%: M%7=I_=9'(1MB?83L/^_?J2AK:J M!"_QS.2<,V=\R4 M@*@B24G&L^R6*=%I6N2Q]FJ*' BR\=4WK0H$5 M.9MY5:= VPXU,5!OZ?UBLUL%1 3\Z6"T)S$)WO>([R%YJ;8T"Q9 0NF"@O#+ M 1Y RB#D&W],FE\M _$T/JH_Q6F]^[VP\(#R;U>YUIO-**F@%H-T;S@^PS3" M.@B6*&W\DG*P#M610HD2GVGM=%S'].?N=J)=)_")P&?"KRP:3XVBS4?A1)$; M'(GM13B[Q<;#31#QRL1[LS&-TZ?JH5BLLYP=@M 99I

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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 58 159 1 false 18 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.ashs.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Statements 3 false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Sheet http://www.ashs.com/role/CondensedConsolidatedStatementOfShareholdersEquity CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Statements 5 false false R6.htm 106 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 107 - Disclosure - Basis of Presentation Sheet http://www.ashs.com/role/BasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 108 - Disclosure - Per Share Amounts Sheet http://www.ashs.com/role/PerShareAmounts Per Share Amounts Notes 8 false false R9.htm 109 - Disclosure - Stock-based Compensation Sheet http://www.ashs.com/role/StockbasedCompensation Stock-based Compensation Notes 9 false false R10.htm 110 - Disclosure - Investment in Equity Securities Sheet http://www.ashs.com/role/InvestmentInEquitySecurities Investment in Equity Securities Notes 10 false false R11.htm 111 - Disclosure - Fair Value of Financial Instruments Sheet http://www.ashs.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 11 false false R12.htm 112 - Disclosure - Repurchase of Common Stock Sheet http://www.ashs.com/role/RepurchaseOfCommonStock Repurchase of Common Stock Notes 12 false false R13.htm 113 - Disclosure - Income Taxes Sheet http://www.ashs.com/role/IncomeTaxes Income Taxes Notes 13 false false R14.htm 114 - Disclosure - Per Share Amounts (Tables) Sheet http://www.ashs.com/role/PerShareAmountsTables Per Share Amounts (Tables) Tables http://www.ashs.com/role/PerShareAmounts 14 false false R15.htm 115 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.ashs.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.ashs.com/role/StockbasedCompensation 15 false false R16.htm 116 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.ashs.com/role/FairValueOfFinancialInstruments 16 false false R17.htm 117 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.ashs.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) Details http://www.ashs.com/role/BasisOfPresentation 17 false false R18.htm 118 - Disclosure - Per Share Amounts (Details) Sheet http://www.ashs.com/role/PerShareAmountsDetails Per Share Amounts (Details) Details http://www.ashs.com/role/PerShareAmountsTables 18 false false R19.htm 119 - Disclosure - Per Share Amounts (Details Textual) Sheet http://www.ashs.com/role/PerShareAmountsDetailsTextual Per Share Amounts (Details Textual) Details http://www.ashs.com/role/PerShareAmountsTables 19 false false R20.htm 120 - Disclosure - Stock-based Compensation (Details) Sheet http://www.ashs.com/role/StockbasedCompensationDetails Stock-based Compensation (Details) Details http://www.ashs.com/role/StockbasedCompensationTables 20 false false R21.htm 121 - Disclosure - Stock-based Compensation (Details 1) Sheet http://www.ashs.com/role/StockbasedCompensationDetails1 Stock-based Compensation (Details 1) Details http://www.ashs.com/role/StockbasedCompensationTables 21 false false R22.htm 122 - Disclosure - Stock-based Compensation (Details Textual) Sheet http://www.ashs.com/role/StockbasedCompensationDetailsTextual Stock-based Compensation (Details Textual) Details http://www.ashs.com/role/StockbasedCompensationTables 22 false false R23.htm 123 - Disclosure - Investment in Equity Securities (Details Textual) Sheet http://www.ashs.com/role/InvestmentInEquitySecuritiesDetailsTextual Investment in Equity Securities (Details Textual) Details http://www.ashs.com/role/InvestmentInEquitySecurities 23 false false R24.htm 124 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://www.ashs.com/role/FairValueOfFinancialInstrumentsTables 24 false false R25.htm 125 - Disclosure - Repurchase of Common Stock (Details Textual) Sheet http://www.ashs.com/role/RepurchaseOfCommonStockDetailsTextual Repurchase of Common Stock (Details Textual) Details http://www.ashs.com/role/RepurchaseOfCommonStock 25 false false All Reports Book All Reports ams-20160331.xml ams-20160331.xsd ams-20160331_cal.xml ams-20160331_def.xml ams-20160331_lab.xml ams-20160331_pre.xml true true ZIP 42 0001144204-16-101006-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-101006-xbrl.zip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